Thapsigargin antiviral research note

  • Thread starter Thread starter jim mcnamara
  • Start date Start date
  • Tags Tags
    Research
Click For Summary

Discussion Overview

The discussion centers around the antiviral properties of thapsigargin, particularly its potential effectiveness against various viruses, including coronaviruses. Participants explore the implications of recent research findings, the mechanisms of action of thapsigargin, and its potential applications in treatment and prophylaxis. The conversation touches on both theoretical and practical aspects of using thapsigargin in medical contexts.

Discussion Character

  • Exploratory
  • Technical explanation
  • Debate/contested

Main Points Raised

  • Some participants note that thapsigargin has been reported to reduce viral replication in several virus types, including coronaviruses, based on animal model studies.
  • There is a discussion about whether thapsigargin could be used prophylactically or only as an early treatment for viral infections.
  • One participant highlights that the evidence for thapsigargin's effectiveness comes from cultured cell studies, which may not accurately reflect real human infections.
  • Concerns are raised regarding the side effects of thapsigargin, particularly if used systemically or long-term, as it targets a host cell protein rather than viral proteins.
  • Another participant mentions that thapsigargin is known to be a tumor promoter in some contexts, raising questions about its safety for prophylactic use.
  • There is a light-hearted acknowledgment of the plant source of thapsigargin, Thapsia garganica, referred to as 'deadly carrot', which could pose public relations challenges.

Areas of Agreement / Disagreement

Participants express a mix of curiosity and caution regarding the use of thapsigargin as an antiviral treatment. While some see potential benefits, others raise significant concerns about its safety and efficacy, indicating that the discussion remains unresolved with multiple competing views.

Contextual Notes

Limitations include the reliance on cultured cell studies, which may not translate to clinical effectiveness, and the potential side effects associated with targeting host cell proteins. The discussion also reflects uncertainty about the appropriate contexts for thapsigargin's use.

jim mcnamara
Mentor
Messages
4,789
Reaction score
3,852
TL;DR
Thapsigargin therapy is very effective antiviral, per this note.
Research note:
https://nottingham-repository.worktribe.com/output/5270247
Popular science note:
https://scitechdaily.com/powerful-a...-that-could-change-how-epidemics-are-managed/

The research note was hard to get to because there seems to be a copyright embargo1 on the primary paper in the journal "Viruses". Which I could not see, obviously.

The claim is that thapsigargin is effective at reducing viral replication - several virus types including Coronaviruses. Covid-19 is a Coronavirus and seems to be effected as well. This is not a case study, it uses animal models - my assumption.

Thapsigargin is a topic of a large number of other papers discussing properties of the compound - mostly biomedical.

A search in Google Scholar 'thapsigargin' will present with loads options for each flavor of secondary criterion. The point is the compound has lots of reports of interesting properties, which reduces the chances of this research note being a complete anomaly.

I would file it under the 'I hope that some day this has proven merit' section.

1 Copyright embargo: https://en.wikipedia.org/wiki/Embargo_(academic_publishing)
In academic publishing, an embargo is a period during which access to academic journals is not allowed to users who have not paid for access (or have access through their institution).

If anyone can see the original, please correct anything that I managed to mess up above.

-- truly unhelpful in this case. It limits what we can reasonably get from either article, although the pop sci article has hyperbole, IMO. Which you should probably ignore.
 
  • Informative
Likes   Reactions: berkeman
Biology news on Phys.org
jim mcnamara said:

Interesting. Would it be used prophylactically somehow, or just as an early treatment?
  • effective against viral infection when used before or during active infection
  • able to prevent a virus from making new copies of itself in cells for at least 48 hours after a single 30-minute exposure.
 
The full text of the article is available here (it should be open access and freely available): https://www.mdpi.com/1999-4915/13/2/234

A few notes:
  • The evidence in the paper is based on studies of viral replication in cultured cells, which can be a poor model for what occurs in real infections in the human body. Several drugs that seem to work in experiments with cultured cells perform poorly in the clinic (e.g. hydroxychloroquine).
  • Unlike most antiviral drugs (which target proteins encoded by the virus), thapsigargin targets a protein inside of the host cell (an ER calcium pump). While this could account for its ability to prevent replication of a broad spectrum of unrelated viruses, it's also likely that inhibition of that protein is causing a lot of other problems with the cells. Side effects of the drug would be a major concern if it were being delivered systemically, especially if used long term in a prophylactic manner.
 
  • Informative
  • Like
Likes   Reactions: jim mcnamara and berkeman
It seems to be a possible therapy for people with infections. This article:
https://en.wikipedia.org/wiki/Thapsigargin
indicates that it is a tumor promoter in some instances.

A priori, taking it like prophylactically, like aspirin to stave off a possible infection, does not sound wonderful to me. If you are in the infective phase or early phase II of Covid-19, and you have known high risk factors, maybe it would be okay. Can't say for sure. The stuff apparently can be administered PO -- orally since it is water soluble.

Also, just for fun, the stuff is extracted from a plant Thapsia garganica. The common name is 'deadly carrot' o0)

Thank you @Ygggdrasil
 
jim mcnamara said:
Also, just for fun, the stuff is extracted from a plant Thapsia garganica. The common name is 'deadly carrot'
Whoops! That's going to be a PR problem... :wink:
 
  • Like
Likes   Reactions: jim mcnamara
berkeman said:
Whoops! That's going to be a PR problem... :wink:
Nah, the vendors will just give it a nickname.
 

Similar threads

Replies
0
Views
1K
  • · Replies 0 ·
Replies
0
Views
2K
  • · Replies 43 ·
2
Replies
43
Views
7K
  • · Replies 8 ·
Replies
8
Views
2K
  • · Replies 2 ·
Replies
2
Views
1K
Replies
4
Views
1K
  • · Replies 30 ·
2
Replies
30
Views
7K
  • · Replies 1 ·
Replies
1
Views
2K
Replies
4
Views
2K
  • · Replies 10 ·
Replies
10
Views
3K